MedTrace Logo

Financial Incentives for Smoking Cessation Among Disadvantaged Pregnant Women

NCT02210832 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 257

Last updated 2023-08-24

Study results available
· View outcomes & findings →

Summary

Investigators will examine whether adding financial incentives to current best practices for smoking cessation during pregnancy (i.e., referral to pregnancy-specific counseling using a telephone quit line) increases cessation rates and improves infant health. While more expensive upfront compared to best practices alone, the investigators hypothesize that this treatment approach will be economically justified by the later cost savings associated with more women quitting, having healthier babies, and needing less healthcare. It should also help to reduce the greater risk for health problems often seen among those who less well off economically.

Conditions

  • Cigarette Smoking

Interventions

BEHAVIORAL

Best practices

BEHAVIORAL

financial incentives

financial incentives provided contingent on biochemically confirmed smoking abstinence

Sponsors & Collaborators

Principal Investigators

  • Stephen T Higgins, PhD · University of Vermont

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2019-01-31
Completion
2020-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02210832 on ClinicalTrials.gov